SMPD1 and Parkinson disease: These suggesting that SMPD1 mutations may disrupt the conversion of sphingomyelin to ceramide, leading to sphingomyelin accumulation, ceramide depletion, and subsequent α-synuclein aggregation, which may trigger neuroinflammation and the occurrence of PD.